SNP information rs6275

Research and publications:

  16867246   Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients.

  18077373   Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

  18154681   A lesson not learned: allele misassignment.

  18305461   Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.

  18477981   [The association study of the DRD2 gene C939T polymorphism and schizophrenia.].

  18698231   Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.

  18829695   Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.

  18838251   Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia.

  19197363   A genome-wide investigation of SNPs and CNVs in schizophrenia.

  19207030   Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.

  19373123   Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.

  19512960   Genetic diagnostics of functional variants of the human dopamine D2 receptor gene.

  19590515   Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese.

  19772578   Two-stage case-control association study of dopamine-related genes and migraine.

  19911060   Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint.

  19913597   An association study of DRD2 gene polymorphisms with schizophrenia in a Chinese Han population.

  20191112   The Genetics of Anorexia Nervosa: Current Findings and Future Perspectives.

  20981002   Breaking barriers in the genomics and pharmacogenetics of drug addiction

  21095016   Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women.

  21354244   The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits.

  21519536   No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients.

  21948099   Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?

  22290307   Predictive index for the onset of medication overuse headache in migraine patients.

  22615781   Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study.

  22650965   Paradox of schizophrenia genetics: is a paradigm shift occurring?

  22875483   Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility.

  22963930   Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent.

  22970887   The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems.

  23856854   Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.

  24086514   Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study.

  24724616   Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and type 2 diabetes susceptibility.

  25741868   Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

  26044620   Gene network analysis shows immune-signaling and ERK1/2 as novel genetic markers for multiple addiction phenotypes: alcohol, smoking and opioid addiction.

  26081799   Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer.

  26370377   Recurrent miscarriage is associated with the dopamine receptor (DRD2) genotype.

  27159875   Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.

  27217270   Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.

  27895608   Genetic Consideration of Schizotypal Traits: A Review.

  28085950   Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia.

  29048744   Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems.

  29255361   Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia.

  29495204   [Association between DRD2 gene polymorphisms and the dosage used on methadone maintenance treatment program].

  29623639   Pharmacogenetics of Opioid Use Disorder Treatment.

  29966133   Association between Polymorphisms of the DRD2 and ANKK1 Genes and Suicide Attempt: A Preliminary Case-Control Study in a Mexican Population.

  29992684   A systematic review: Candidate gene and environment interaction on alcohol use and misuse among adolescents and young adults.

  30093869   Biological Predictors of Clozapine Response: A Systematic Review.

  30103286   Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis.

  30607769   Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population.

  30967134   A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia.

  31144779   Dopamine receptor D2 and ankyrin repeat domain containing one in temporomandibular disorder of adolescents.

  31744450   Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine.

  33187731   A Novel Variant in Dopamine Receptor Type 2 Gene is Associated with Schizophrenia.

  33524518   Genetic diversity of the North African population revealed by the typing of SNPs in the DRD2/ANKK1 genomic region.

  34342556   Association study of Catechol-O-Methyltransferase (COMT) rs4680 Val158Met gene polymorphism and suicide attempt in Mexican adolescents with major depressive disorder.

  34440083   Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients.

  34518136   Genetic polymorphisms are associated with alterations in anxiety levels and vital signs in patients undergoing third molar extractions.

  34871222   Influence of genetic variants of opioid-related genes on opioid-induced adverse effects in patients with lung cancer: A STROBE-compliant observational study.

  35140610   Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.

  36043564   Temporomandibular disorder in construction workers associated with ANKK1 and DRD2 genes.

  36082055   Brain Magnetic Resonance Imaging Features of Nicotine-Dependent Individuals and Its Correlation with Polymorphisms of Dopamine D Receptor Gene.

  34945793   Genetic markers as risk factors for the development of impulsive-compulsive behavior in patients with Parkinson's disease receiving dopaminergic therapy.